Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.355
+0.025 (1.85%)
Aug 14, 2025, 11:45 AM - Market open
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
$57,821
Profits / Employee
-$129,991
Market Cap
11.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117 | -25 | -17.61% |
| Dec 31, 2023 | 142 | 5 | 3.65% |
| Dec 31, 2022 | 137 | -4 | -2.84% |
| Dec 31, 2021 | 141 | 10 | 7.63% |
| Dec 31, 2020 | 131 | -12 | -8.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVGN News
- 2 days ago - Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - PRNewsWire
- 16 days ago - Evogene Schedules Second Quarter 2025 Financial Results Release - PRNewsWire
- 5 weeks ago - Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL - PRNewsWire
- 2 months ago - Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PRNewsWire
- 3 months ago - Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evogene Reports First Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Evogene Schedules First Quarter 2025 Financial Results Release - PRNewsWire
- 4 months ago - ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - PRNewsWire